Lazarus JV

September 3, 2025
Closing the Gap in HCV Care: Strategic Collaboration Between Industry, Academic, Community, and Nonprofit Researchers
Increased funding for hepatitis C virus (HCV) research and care delivery is needed to support effective programs for vulnerable communities and meet the WHO 2030 targets for HCV elimination. Strategic collaborations among industry and nonindustry stakeholders can address this need. Establishing clear expectations, transparency, and investigator independence in these partnerships can enhance and accelerate HCV […]

Read More
October 5, 2022
Securing Wider EU Commitment to the Elimination of Hepatitis C Virus
Summary In 2016, the Hepatitis B and C Public Policy Association (HepBCPPA), gathered all the main stakeholders in the field of hepatitis C virus (HCV) to launch the now landmark HCV Elimination Manifesto, calling for the elimination of HCV in the EU by 2030. Since then, many European countries have made progress towards HCV elimination. […]

Read More
February 16, 2022
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
Summary Background Since the release of the first global hepatitis elimination targets in 2016, and until the COVID-19 pandemic started in early 2020, many countries and territories were making progress toward hepatitis C virus (HCV) elimination. This study aims to evaluate HCV burden in 2020, and forecast HCV burden by 2030 given current trends. Methods This analysis […]

Read More
December 1, 2021
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
Summary Background & aims Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent, yet largely underappreciated liver condition which is closely associated with obesity and metabolic disease. Despite affecting an estimated 1 in 4 adults globally, NAFLD is largely absent on national and global health agendas. Methods We collected data from 102 countries, accounting for […]

Read More
January 19, 2021
Progress towards hepatitis C virus elimination in high-income countries: An updated analysis
Summary Background & aims Elimination of HCV by 2030, as defined by the World Health Organization (WHO), is attainable with the availability of highly efficacious therapies. This study reports progress made in the timing of HCV elimination in 45 high-income countries between 2017 and 2019. Methods Disease progression models of HCV infection for each country […]

Read More
July 28, 2020
The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data
Summary Background New hepatitis C virus (HCV) treatments spurred the World Health Organization (WHO) in 2016 to adopt a strategy to eliminate HCV as a public health threat by 2030. To achieve this, key policies must be implemented. In the absence of monitoring mechanisms, this study aims to assess the extent of policy implementation from […]

Read More
July 27, 2020
Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
Summary Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C? In 2019, a Lancet Gastroenterology & Hepatology Commission on accelerating the elimination of viral hepatitis reported on the status of 11 viral hepatitis policy indicators in 66 countries and territories with the heaviest burden by global region. […]

Read More
March 24, 2020
A micro-elimination approach to addressing hepatitis C in Turkey
Summary Background In 2016, WHO passed the Global Health Sector Strategy on Viral Hepatitis (GHSS), calling for its elimination by 2030. Two years later, Turkey approved a strategy to reach the WHO targets. This study reports new national prevalence data, breaks it down by subpopulation, and models scenarios to reach HCV elimination. Methods Literature was […]

Read More
September 3, 2018
The hepatitis B epidemic and the urgent need for cure preparedness
Summary More than 250 million people worldwide are chronically infected with the hepatitis B virus (HBV). In this Comment, members of the International Coalition to Eliminate HBV appraise the current policy environment and the need for appropriate cure research and preparedness to complement the WHO global elimination strategy, the HBV vaccine and the well- tolerated […]

Read More
July 9, 2018
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations
Summary The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World Health Organization to define ambitious targets for eliminating HCV as a public health threat by 2030. Formidable obstacles to reaching this goal can best be overcome through a micro-elimination approach, which entails pursuing elimination goals in discrete populations through multi-stakeholder initiatives […]

Read More